Electroencephalography Systems/Devices Market Report and Forecast 2024-2032

According to the report, the global electroencephalography systems/devices market is projected to grow at a CAGR of 9.4% between 2024 and 2032 reaching a value of approximate USD 2.698 Billion by 2032.. Aided by the rising prevalence of neurological disorders and the technological advancements in brain-computer interface applications, the market is expected to grow significantly by 2032.

Electroencephalography (EEG) systems or devices are primarily used to record electrical activity of the brain. The non-invasive nature of EEG makes it a prominent choice for diagnosing and monitoring various conditions, including epilepsy, sleep disorders, and even some levels of brain injuries. EEG systems are integral to many neurological assessments, providing crucial insights into brain activities and aiding in the development of treatment plans for patients.

The surge in the global incidence of neurological disorders, particularly epilepsy and dementia, has been instrumental in fuelling the demand for EEG systems/devices. As the global population ages, there is a significant rise in the number of individuals requiring neurophysiological monitoring, which, in turn, bolsters the electroencephalography systems/devices market demand.

Moreover, advancements in technology have enabled the evolution of EEG devices from mere diagnostic tools to devices that can potentially facilitate communication for patients with severe neuromuscular disorders. The advent of brain-computer interfaces, which often rely on EEG readings, showcases the potential future applications of these devices, beyond traditional medical diagnostics.

According to the electroencephalography systems/devices market analysis, the escalating trend of telemedicine and home healthcare has brought portable EEG devices to the fore. As patients and healthcare professionals lean towards remote monitoring solutions, especially in the wake of global events like the COVID-19 pandemic, compact and user-friendly EEG systems have gained unprecedented traction. These devices offer the convenience of monitoring without the need for extended hospital stays, making them attractive for both clinicians and patients.

Research and academia have also recognised the utility of EEG systems. Institutions engaged in neuroscience research heavily rely on EEG for understanding brain functions, cognitive responses, and the underpinnings of various psychological conditions. This has spurred investments in more sophisticated and high-resolution EEG systems, thereby contributing to electroencephalography systems/devices market growth.

The pharmaceutical sector's increasing focus on drug development for neurodegenerative conditions also provides an impetus to the EEG systems/devices market. EEG remains a fundamental tool for monitoring drug effects on brain activity during clinical trials, ensuring the safety and efficacy of novel formulations.

Market Segmentation

The market can be divided based on product, portability, end use, and region.

Market Breakup by Product

• 8-channel EEG
• 21-channel EEG
• 25 channel EEG
• 32-channel EEG
• 40-channel EEG
• Multichannel EEG

Market Breakup by Portability

• Standalone Devices
• Portable Devices

Market Breakup by End Use

• Hospitals
• Diagnostic Centres

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Competitive Landscape

The report looks into the market shares, plant turnarounds, capacities, investments, and mergers and acquisitions, among other major developments, of the leading companies operating in the global electroencephalography systems/devices market. Some of the major players explored in the report are as follows:

• Compumedics Ltd.
• Natus Medical, Inc.
• Electrical Geodesics, Inc.
• NeuroWave Systems, Inc.
• Cadwell Laboratories, Inc.
• Nihon Kohden Corporation
• Medtronic plc
• Others